Bayer Research and Development Expenses 2012-2025 | BAYRY

Bayer research and development expenses for the twelve months ending December 31, 2025 were $6.527B, a 2.85% decline year-over-year.

  • Bayer annual research and development expenses for 2025 were $6.527B, a 2.85% decline from 2024.
  • Bayer annual research and development expenses for 2024 were $6.719B, a 15.58% increase from 2023.
  • Bayer annual research and development expenses for 2023 were $5.813B, a 16.05% decline from 2022.

Bayer Research and Development Expenses 2012-2025 | BAYRY

  • Bayer annual research and development expenses for 2025 were $6.527B, a 2.85% decline from 2024.
  • Bayer annual research and development expenses for 2024 were $6.719B, a 15.58% increase from 2023.
  • Bayer annual research and development expenses for 2023 were $5.813B, a 16.05% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Innoviva (INVA)$1.8B